Cargando…

An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012

The aim of this study was to measure the potential of production and the capacity used in the pharmaceutical industry. Capacity use is the actual production rate to the potential output, which reflects the gap between actual production and production capacity. Through econometric methods, translog c...

Descripción completa

Detalles Bibliográficos
Autores principales: Annabi, Majid, Kebriaeezadeh, Abbas, Mohammadi, Timor, Marashi Shoshtari, Seyed Nasrolah, Abedin Dorkoosh, Farid, Pourreza, Abolghasem, Heydari, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843327/
https://www.ncbi.nlm.nih.gov/pubmed/29552074
_version_ 1783305069940178944
author Annabi, Majid
Kebriaeezadeh, Abbas
Mohammadi, Timor
Marashi Shoshtari, Seyed Nasrolah
Abedin Dorkoosh, Farid
Pourreza, Abolghasem
Heydari, Hassan
author_facet Annabi, Majid
Kebriaeezadeh, Abbas
Mohammadi, Timor
Marashi Shoshtari, Seyed Nasrolah
Abedin Dorkoosh, Farid
Pourreza, Abolghasem
Heydari, Hassan
author_sort Annabi, Majid
collection PubMed
description The aim of this study was to measure the potential of production and the capacity used in the pharmaceutical industry. Capacity use is the actual production rate to the potential output, which reflects the gap between actual production and production capacity. Through econometric methods, translog cost function in the short run along with functions of share cost of production factors is estimated through seemingly unrelated repeated regression (SURE) as a multivariate regression analysis provided by zeller. During the study the capacity used is decreasing. The capacity used, which calculated by weighted average, also decreased and the amount during the study period is much less than the simple average of the industry. Average capacity utilization in the industry over five years of study is equal to 57% while the average capacity used calculated by the weighted of industry average is 37%. To enhance the economic potential requires a proper use of resources, creation of favorable economic structure and productivity of the industry. Due to the large amount of unused capacity in the pharmaceutical industry there is no need to invest anymore unless in new grounds and it is obvious that more investment will change using capacity.
format Online
Article
Text
id pubmed-5843327
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-58433272018-03-16 An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012 Annabi, Majid Kebriaeezadeh, Abbas Mohammadi, Timor Marashi Shoshtari, Seyed Nasrolah Abedin Dorkoosh, Farid Pourreza, Abolghasem Heydari, Hassan Iran J Pharm Res Original Article The aim of this study was to measure the potential of production and the capacity used in the pharmaceutical industry. Capacity use is the actual production rate to the potential output, which reflects the gap between actual production and production capacity. Through econometric methods, translog cost function in the short run along with functions of share cost of production factors is estimated through seemingly unrelated repeated regression (SURE) as a multivariate regression analysis provided by zeller. During the study the capacity used is decreasing. The capacity used, which calculated by weighted average, also decreased and the amount during the study period is much less than the simple average of the industry. Average capacity utilization in the industry over five years of study is equal to 57% while the average capacity used calculated by the weighted of industry average is 37%. To enhance the economic potential requires a proper use of resources, creation of favorable economic structure and productivity of the industry. Due to the large amount of unused capacity in the pharmaceutical industry there is no need to invest anymore unless in new grounds and it is obvious that more investment will change using capacity. Shaheed Beheshti University of Medical Sciences 2017 /pmc/articles/PMC5843327/ /pubmed/29552074 Text en © 2017 by School of Pharmacy,Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Annabi, Majid
Kebriaeezadeh, Abbas
Mohammadi, Timor
Marashi Shoshtari, Seyed Nasrolah
Abedin Dorkoosh, Farid
Pourreza, Abolghasem
Heydari, Hassan
An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
title An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
title_full An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
title_fullStr An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
title_full_unstemmed An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
title_short An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012
title_sort estimation of the potential utilization in iranian pharmaceutical industry involved in the stock exchange, 2008-2012
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843327/
https://www.ncbi.nlm.nih.gov/pubmed/29552074
work_keys_str_mv AT annabimajid anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT kebriaeezadehabbas anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT mohammaditimor anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT marashishoshtariseyednasrolah anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT abedindorkooshfarid anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT pourrezaabolghasem anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT heydarihassan anestimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT annabimajid estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT kebriaeezadehabbas estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT mohammaditimor estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT marashishoshtariseyednasrolah estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT abedindorkooshfarid estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT pourrezaabolghasem estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012
AT heydarihassan estimationofthepotentialutilizationiniranianpharmaceuticalindustryinvolvedinthestockexchange20082012